ICJEM
Intercontinental Journal of Emergency Medicine

The Intercontinental Journal of Emergency Medicine aims to publish issues related to all fields of emergency medicine and all specialties involved in the management of emergencies in the hospital and prehospital environment of the highest scientific and clinical value at an international level and accepts articles on these topics. This journal is indexed by indices that are considered international scientific journal indices (DRJI, ESJI, OAJI, etc.). According to the current Associate Professorship criteria, it is within the scope of International Article 1-d. Each article published in this journal corresponds to 5 points.

eISSN: 2980-1400
Creative Commons CC BY-NC-ND 4.0 International License.
EndNote Style

Online Manuscript System

Index
Case Report
Priapism a rare side effect of Cilostazol
Abstract
We present the case of priapism associated with cilostazol. A rare side effect of cilostazol on the genitourinary system. Priapism is a long-lasting erection that occurs without sexual arousal or stimulation. It can cause irreversible damage on penis. Therefore, urgent treatment is required. Priapism can be treated with aspiration, intracavernous injection or, as in our case, with surgical ligation. Priapism is a common side effect of phosphodiesterase 5 inhibitors. However, this situation is very rare for cilostazol, one of the phosphodiesterase 3 inhibitors.

Keywords : Phosphodiesterase 3 inhibitor, priapism, leukocytosis, thrombocytosis, aspiration

Download Article


1. Van der Horst C, Stuebinger H, Seif C, Melchior D, Martínez-Portillo FJ, Juenemann KP. Priapism-etiology, pathophysiology and management.Int Braz J Urol. 2003;29(5):391-400.
2. Shigehara K, Namiki M. Clinical management of priapism: a review.World J Mens Health. 2016;34(1):1-8.
3. Baños JE, Bosch F, Farré M. Drug-induced priapism. Its aetiology, incidence and treatment.Med Toxicol Adverse Drug Exp. 1989;4(1):46-58.
4. Kherallah RY, Khawaja M, Olson M, Angiolillo D, Birnbaum Y. Cilostazol: a review of basic mechanisms and clinical uses.Cardiovasc Drugs Ther. 2022;36(4):777-792.
5. Perez P, Esteban C, Sauquillo JC, et al. Cilostazol and outcome in outpatients with peripheral artery disease.Thromb Res. 2014;134(2):331-335.
6. Nomoto H, Matsubara Y, Ichimiya Y, Arai H. Acute renal failure caused by cilostazol in a patient with Alzheimer's disease.Geriatr Gerontol Int. 2017; 17(1):171-172.
7. Shima H, Tashiro M, Yamada S, et al. Cilostazol-induced acute tubulointerstitial nephritis accompanied by IgA nephropathy: a case report.BMC Nephrol. 2018;19(1):52..
8. Samidurai A, Xi L, Das A, Kukreja RC. Beyond erectile dysfunction: cGMP-specific phosphodiesterase 5 inhibitors for other clinical disorders.Annu Rev Pharmacol Toxicol. 2023;63:585-615.
9. Kherallah RY, Khawaja M, Olson M, Angiolillo D, Birnbaum Y. Cilostazol: a review of basic mechanisms and clinical uses.Cardiovasc Drugs Ther. 2022;36(4):777-792.
10. Bedenis R, Stewart M, Cleanthis M, Robless P, Mikhailidis DP, Stansby G. Cilostazol for intermittent claudication.Cochrane Database Syst Rev. 2014; 2014(10):CD003748.
11. Rogers KC, Oliphant CS, Finks SW. Clinical efficacy and safety of cilostazol: a critical review of the literature.Drugs.2015;75(4):377-395.
12. Bangalore S, Singh A, Toklu B, et al. Efficacy of cilostazol on platelet reactivity and cardiovascular outcomes in patients undergoing percutaneous coronary intervention: insights from a meta-analysis of randomised trials.Open Heart.2014;1(1):e000068.
13. LiverTox: clinical and research information on drug-induced liver injury [internet].National institute of diabetes and digestive and kidney diseases; bethesda (MD): Dec 1, 2017. Cilostazol.
Article available in :
Volume 2, Issue 4, 2024
Page : 90-92
https://doi.org/10.51271/ICJEM-0047
Article Information
Received : 19 Eyl 2024
Accepted : 26 Eyl 2024
Published : 20 Ara 2024
Corresponding Author :

Sema Kaya: Department of Emergency Medicine, Ankara Bilkent City Hospital, Ankara, Turkiye

[email protected]
Citation : Kaya S, Yıldız İU. Priapism a rare side effect of Cilostazol. Intercont J Emerg Med. 2024;2(4):90-92.

Read: 7
Cited: 0
Download : 3
_Footer